AzTrials
AzTrials

Gestatiaonl Diabetes MellitusNCT07851753

Lumbopelvic Stability in Gestational Diabetes Mellitus

An observational study of Gestatiaonl Diabetes Mellitus, run by Riphah International University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this comparative cross-sectional study is to learn about the effects of gestational diabetes on lumbopelvic stability in primigravida subjects. The main question it aims to answer is: Does gestational diabetes effect lumbopelvic stability during pregnancy? Read more about this study

Who is it for?
Ages 20 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Gestatiaonl Diabetes Mellitus
How many people
170 participants
Where
1 sitePakistan
Study dates
1 May 2026to 1 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: pregnant female with and without gestational diabetes

Who may be able to join

  • Pregnant women (2nd trimester)
  • Primi gravida
  • Diagnosed cases of gestational diabetes mellitus (for case group)
  • Healthy pregnant women (for control group)
  • Singleton pregnancy
  • Ability to perform functional tests (ASLR and Y Balance Test)
  • BMI within normal to overweight range (e.g., 18.5-29.9 kg/m²)
  • Stable medical condition

Who cannot join

  • • High-risk pregnancy (e.g., preeclampsia, placenta previa)
  • Previous spinal or pelvic surgery
  • History of low back pain with neurological deficit
  • Diagnosed spinal disorders (disc herniation, spondylolisthesis, severe scoliosis)
  • Pelvic fractures
  • Neurological disorders (e.g., stroke, neuropathy)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

imran Professor, Faculty of Rehabilitation & Allied Health Sciences, PhD contact

03324390125

imran.amjad@riphah.edu.pk

Pakistan1 site, 1 recruiting
  • Ganga Ram Hospital, Fatima Memorial Hospital, Gulab Devi Hospital

    Lahore, Punjab Province, 6400

    hina gul assistant professor, PhD*, 03214979172, hina.gul@riphah.edu.pk

    Amna Tariq Khan, Urooj Ahmed DPT students, DPT

    Recruiting

Other trials in Pakistan

About this study

Official title: Comparison of Lumbopelvic Stability in Pregnant Women With and Without Gestational Diabetes Mellitus

The goal of this comparative cross-sectional study is to learn about the effects of gestational diabetes on lumbopelvic stability in primigravida subjects. The main question it aims to answer is:

Does gestational diabetes effect lumbopelvic stability during pregnancy?

Read the detailed description

This comparative cross-sectional study will be conducted over ten months at Fatima Memorial Hospital, Gulab Devi Hospital, and Ganga Ram Hospital. A total of 170 primigravida women in their second trimester (aged 20-40 years, singleton pregnancies, BMI 18.5-29.9 kg/m²) will be enrolled through non-probability convenient sampling and divided into two equal groups of 85 women each, with and without GDM. Women with high-risk pregnancies or spinal/pelvic comorbidities will be excluded. Lumbopelvic stability, dynamic balance, and pain intensity will be assessed by using the Active Straight Leg Raise (ASLR) test, Y-Balance Test (YBT), and Visual Analogue Scale (VAS), respectively, and data will be analyzed by using SPSS version 27.0.

Keywords
pregnancy, core stability, female, gestational diabetes, human
Medical subject headings
Diabetes, Gestational

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale (VAS)

    The Visual Analogue Scale (VAS) is a simple tool used to measure subjective pain intensity.It consists of a 10-cm (100-mm) horizontal line.

    0 = No pain 10 (or 100 mm) = Worst pain imaginable The participant marks a point on the line representing their current pain intensity.

    The distance from 0 to the participant's mark is measured and recorded as the pain score.

    Measured: 12th week

  2. Active Straight Leg Raise

    The Active Straight Leg Raise (ASLR) test is a clinical test used to assess lumbopelvic load transfer and functional stability of the pelvis.

    The participant lies supine with both legs straight. They actively raise one straight leg approximately 20 cm off the examination surface without bending the knee.

    Difficulty or inability to perform the movement may indicate impaired lumbopelvic stability/load transfer.

    It can be scored using a 0-5 difficulty scale, where higher scores indicate greater difficulty.

    Measured: 12th week

  3. Y-Balance Test (YBT)

    The Y-Balance Test is a dynamic balance test used to assess postural control, functional stability, and lower-extremity/lumbopelvic control.

    It requires the participant to maintain a single-leg stance while reaching the opposite leg in three directions:

    Anterior Posteromedial Posterolateral

    The reach distances are recorded and can be normalized to leg length to calculate a composite score.

    Measured: 12th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2026
  2. Study start1 May 2026
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
170 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07851753
Sponsor's protocol ID
REC/RCR&AHS/26/3003
Status last verified
Sep 2026
First submitted
26 Sep 2026
Last updated
1 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Stern C, Schwarz S, Moser G, Cvitic S, Jantscher-Krenn E, Gauster M, Hiden U. Placental Endocrine Activity: Adaptation and Disruption of Maternal Glucose Metabolism in Pregnancy and the Influence of Fetal Sex. Int J Mol Sci. 2021 Nov 24;22(23):12722. doi: 10.3390/ijms222312722.

    PubMed 34884524
  • Moon JH, Jang HC. Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications. Diabetes Metab J. 2022 Jan;46(1):3-14. doi: 10.4093/dmj.2021.0335. Epub 2022 Jan 27.

    PubMed 35135076
  • Chauhan A, Potdar J. Maternal Mental Health During Pregnancy: A Critical Review. Cureus. 2022 Oct 25;14(10):e30656. doi: 10.7759/cureus.30656. eCollection 2022 Oct.

    PubMed 36426343
  • Das S, Das N, Islam R, Harun J. Causes and Prevention of Maternal Complications During Pregnancy in Developing Countries. Asia Pacific Journal of Cancer Research. 2025;2:4-9.

  • Ye J, Li J, Lin Y, Wang Y, Wu J, Zhou Z. Pregnancy: A Comprehensive Review. 2024.

Questions about this trial

What is this clinical trial studying?

An observational study of Gestatiaonl Diabetes Mellitus, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact imran Professor, Faculty of Rehabilitation & Allied Health Sciences, PhD (03324390125, imran.amjad@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (VAS) (time frame: 12th week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07851753, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in